Circulating IL-1β, IL-17, and IP-10 as Potential Predictors of Hepatitis B Virus Infection Prognosis
Table 2
Circulating cytokine and chemokine levels of the study groups.
Groups
Proinflammatory cytokines
Anti-inflammatory cytokine
Chemokines
IL-1β
IL-6
IL-17
IL-10
IL-8
IP-10
MCP-1
MIP-1β
CHB ()
3.69 (2.20–5.30)
15.68 (13.10–28.29)
46.22 (41.07–53.75)
4.86 (4.14–7.82)
49.77 (23.76–203.30)
2456.50 (1682.16–4016.28)
49.60 (34.82–70.83)
228.94 (146.91–452.52)
SC ()
0.95 (0.50–1.51)
16.88 (14.57–20.60)
90.62 (73.95–115.70)
0.40 (0.40–3.02)
33.28 (24.45–52.27)
921.18 (669.29–1514.12)
59.97 (48.94–81.59)
125.49 (92.67–185.55)
Hepatoma ()
0.48 (0.48–2.94)
16.93 (4.10–39.42)
0.57 (0.44–41.07)
0.89 (0.40–7.20)
32.86 (7.40–163.93)
444.35 (235.82–1493.47)
12.53 (7.48–52.13)
57.96 (25.19–169.35)
Control ()
1.13 (0.93–1.88)
5.96 (3.24–11.18)
28.47 (20.74–53.57)
2.57 (1.48–3.63)
30.37 (14.57–44.94)
925.62 (737.16–1286.39)
49.21 (40.92–65.86)
210.33 (70.33–287.92)
<0.001
<0.001
<0.001
<0.001
0.003
<0.001
<0.001
<0.001
Note: Values are reported as median (interquartile), pg/mL. Comparisons among groups were performed using the Kruskal-Wallis H test. Abbreviations: CHB: Chronic hepatitis B; IL: interleukin; SC: Spontaneous clearance; IP-10: Interferon-γ-inducible protein-10; MCP-1: Monocyte chemoattractant protein-1; MIP-1β: macrophage inflammatory protein-1β.